MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Keiretsu Forum
Industry: Silicon Valley, California
CARGO Therapeutics, Inc. (NASDAQ: CRGX)*
Organization & Developments: Cargo Therapeutics
Parents
CARGO Therapeutics, Inc. (NASDAQ: CRGX)*
Children
*Clinical-stage biotechnology company developing next-generation potentially curative CAR T-cell therapies for cancer
*CRG-022 is a CAR T-cell product candidate to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
2024: Cargo Therapeutics: High Venture Interest But Still Early Days For This CAR-T Player
2025: Bay Area biotech firm guts staff, shuts trial after dangerous side effects
2025: CARGO Therapeutics Ends All Programs Despite $368M Cash Position
2025: CARGO Therapeutics: A Gutted CAR T Player Trying To Find New Direction
Jumps
Finance & Acquisitionss: Cargo Therapeutics
Key People: Cargo Therapeutics